Efficacy and safety of anti-PD1 monotherapy or in combination with ipilimumab after BRAF/MEK inhibitors in patients with BRAF mutant metastatic melanoma
========================================================================================================================================================

* Ines Pires da Silva
* Danny Zakria
* Tasnia Ahmed
* Claudia Trojanello
* Florentia Dimitriou
* Clara Allayous
* Camille Gerard
* Lisa Zimmer
* Serigne Lo
* Olivier Michielin
* Celeste Lebbe
* Johanna Mangana
* Paolo Antonio Ascierto
* Douglas B Johnson
* Matteo Carlino
* Alexander Menzies
* Georgina Long